Nucleophilic selectivity ratios of model and clinical alkylating agents by 4- (4'-nitrobenzyl) pyridine competition
Spears, C.P.
Molecular Pharmacology 19(3): 496-504
1981
ISSN/ISBN: 0026-895X PMID: 7266474 Document Number: 169103
Document emailed within 1 workday
Related Documents
Süli-Vargha, H.; Sohár, P. 1994: Reaction with 4-(p-nitrobenzyl)pyridine allows detection of urethane-protected pyroglutamyl residues Peptide Research 7(1): 24-26Buckner, J.C.; Moynihan, T.J. 2001: The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents New England Journal of Medicine 344(9): 686; Author Reply 687-688
Catane, R. 1978: Clinical experience with estramustine phosphate and predinimustine, two steroidal alkylating agents compounds Cancer Treatment Reports 62(8): 1264-1265
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
Schmidt, C.G. 1971: Alkylating cytostatic agents Der Internist 12(Suppl 1): 119-127
Bignold, L.P. 2006: Alkylating agents and DNA polymerases Anticancer Research 26(2b): 1327-1336
Lind, M.J.; Ardiet, C. 1993: Pharmacokinetics of alkylating agents Cancer Surveys 17: 157-188
Frei, E. 1991: The modulation of alkylating agents Seminars in Hematology 28(3 Suppl 4: 22-24
Iamshanov, V.A.; Kraĭz, B.O.; Petrov, A.S. 1973: Interaction of DNA with alkylating agents of different classes Voprosy Onkologii 19(2): 60-62
Lisker, S.A. 1970: Chemotherapy for malignant disease: the alkylating agents Delaware Medical Journal 42(5): 127-130
Babaian, I.S.; Khudaverdian, N.V.; Karapetian, L.G.; Kazarian, R.S.; Sogomonian, L.R. 1997: Comparative study of three antineoplastic alkylating agents on DNA Biofizika 42(2): 542-543
Schmähl, D. 1986: Carcinogenicity of anticancer drugs and especially alkylating agents Iarc Scientific Publications 78: 29-35
Canellos, G.P. 1989: The role of alkylating agents in acute and chronic leukemia Bone Marrow Transplantation 4(Suppl 1): 46-47
Machoń, Z. 1975: Advances made in the chemistry of alkylating agents and treatment of cancer Postepy Higieny i Medycyny Doswiadczalnej 29(4): 443-472
Mittelman, A.; Catane, R.; Murphy, G.P. 1977: New steroidal alkylating agents in advanced stage D carcinoma of the prostate Cancer Treatment Reports 61(2): 307-310
Wheeler, G.P. 1973: Recent advances in the biochemical pharmacology of selected alkylating agents Transplantation Proceedings 5(3): 1167-1170
Romanova, I.N. 1972: Effect of alkylating agents on the ATPase activity of liver mitochondria Biokhimiia 37(4): 846-850
Veremko, L.N.; Telegin, L.I.; Pevnitskii, L.A. 1983: Variability of the sensitivity of human lymphocytes to the antiproliferative action of alkylating agents Biulleten' Eksperimental'noi Biologii i Meditsiny 95(5): 73-75
Lomova, T.I.; Shakhova, I.K.; Shkodinskaia, E.N. 1981: Repair of DNA-protein cross-links induced by antineoplastic alkylating agents Biulleten' Eksperimental'noi Biologii i Meditsiny 92(7): 74-76
Botnick, L.E.; Hannon, E.C.; Hellman, S. 1978: Multisystem stem cell failure after apparent recovery from alkylating agents Cancer Research 38(7): 1942-1947